about
Harry Goldblatt and the discovery of reninBioactive Carbohydrates and Peptides in Foods: An Overview of Sources, Downstream Processing Steps and Associated Bioactivities.The discovery of hypertension: evolving views on the role of the kidneys, and current hot topicsMultifaceted interplay among mediators and regulators of intestinal glucose absorption: potential impacts on diabetes research and treatmentAliskiren: the first renin inhibitor for clinical treatmentIdentification of membrane-bound variant of metalloendopeptidase neurolysin (EC 3.4.24.16) as the non-angiotensin type 1 (non-AT1), non-AT2 angiotensin binding siteNovel Cardiac Intracrine Mechanisms Based on Ang-(1-12)/Chymase Axis Require a Revision of Therapeutic Approaches in Human Heart Disease.Angiotensin receptor type 2 activation induces neuroprotection and neurogenesis after traumatic brain injury.Prorenin and (pro)renin receptor: a review of available data from in vitro studies and experimental models in rodents.The renin-angiotensin system in essential hypertension: associations with cardiovascular risk.Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current statusThe renin angiotensin system as a risk factor for coronary artery disease.Addressing those two that go together: the angiotensin II receptors and their role in blood-flow regulation.Statins, the renin-angiotensin-aldosterone system and hypertension - a tale of another beneficial effect of statins.ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good.The renin-angiotensin system: a biological machine.Renal oxidative stress, oxygenation, and hypertensionFate of angiotension I in the total Bufo melanostictus.Therapeutic potential of renin inhibitors in the management of cardiovascular disorders.Novel roles of nuclear angiotensin receptors and signaling mechanisms.Involvement of glomerular renin-angiotensin system (RAS) activation in the development and progression of glomerular injury.Angiotensin receptor blockers versus ACE inhibitors: prevention of death and myocardial infarction in high-risk populations.Expression of angiotensinogen and receptors for angiotensin and prorenin in the rat and monkey striatal neurons and glial cells.A Swedish view on the diagnosis of renovascular hypertension.The roles of sensitization and neuroplasticity in the long-term regulation of blood pressure and hypertension.The CNS renin-angiotensin system.The renin-angiotensin system and atherosclerosis.Novel roles of intracrine angiotensin II and signalling mechanisms in kidney cells.Evolution of the diffuse neuroendocrine system--clear cells and cloudy origins.Converting enzyme inhibition and blood pressure regulation.Update on tissue renin-angiotensin systems.Are we poised to target ACE2 for the next generation of antihypertensives?The renin-angiotensin system modulates inflammatory processes in atherosclerosis: evidence from basic research and clinical studiesSignificance of genetic polymorphisms of the renin-angiotensin-aldosterone system in cardiovascular and renal disease.Left ventricular hypertrophy and renin-angiotensin system blockade.Managing cardiovascular and renal risk: the potential of direct renin inhibition.The (pro)renin receptor in health and disease.New insights into the renoprotective actions of the renin inhibitor aliskiren in experimental renal disease.The importance of renin-angiotensin blockade in patients with cardio-renal disease.Physiological actions of angiotensin II mediated by AT1 AND AT2 receptors in the brain.
P2860
Q24646178-4C650ABF-5EA1-49EF-827A-385E61D2C71EQ26782314-02AEAED6-439F-493A-AAA0-2FBC4A8298B4Q26830489-362A3DFD-16BB-4CAF-81F7-2F334D7FE676Q28086792-4C674FBC-22A9-4D37-AD3A-6819DC8BD30CQ28272666-70132EBD-C200-41A7-AE6D-2506DA8772FFQ28586322-9AFC9858-9116-4282-B9C1-8074254BF8EEQ30235583-667421AD-161F-4B20-B99D-FD18108D7E02Q30585823-3499F492-037D-49D3-9817-B36EAD3C3690Q31151042-FEBECC3C-E756-497E-B06D-60E8B66C55F4Q33713602-5ABE6DFC-EBCD-467A-969A-8D706735210BQ34124779-ABABAEA5-5DF2-45E1-B4EB-EDFDC46845BDQ34140718-326F2551-0ADE-42DD-801F-55611EDC29D5Q34238307-8CE40F29-F84D-41D2-90B3-7FF1BCE47B24Q34429685-52A3EE80-2D6E-4539-877B-158A0A0264B9Q34784864-36613ACC-127B-438C-8FA1-CF890EB93304Q35229303-8620D0CD-C1B8-4EEC-A23B-3CB0977887BAQ35543371-6117515C-EA31-4614-99B6-52AE557BD26FQ35600222-CF0EC76E-D395-428E-9343-23F755D81068Q35631408-4BEB49A9-B123-41D4-8321-24057F5BF0ECQ35850244-9A1CAC99-83AF-4F51-93F9-FE10AA3CBDB5Q35895028-143766B8-FB74-4F16-85E2-D78DA5847284Q36035236-C3487FFE-B4F7-4BD8-9C67-DB7E1A65B3BCQ36270869-A6B4094F-FCEC-4EFF-BED6-75ECAAAA0436Q36364321-7DCAB703-DF18-4665-B43E-46C3F1C2310EQ36422516-1FF82C1C-3CE1-490A-9FD9-97CB9E4185FEQ36429075-1B96AE23-1A0B-43F5-B609-0DC7F10F0279Q36442587-2956299D-D870-4799-86E7-9FF6583201E6Q36513492-2B02FD3E-B0C4-4613-AFC3-6B210A297474Q36654067-C5C9B354-9DE5-49F4-B845-514091F16350Q37113027-F9CEEDA4-A63A-40F7-BCDE-CF5E81A1771CQ37139367-1CF950D0-47C8-4E46-B30A-62D0E8A467A2Q37151964-A2206EEB-9D5D-491A-B8E9-E8BC40793D15Q37158159-887AE51C-D913-43C5-BB02-53E966B5929EQ37416129-BC85D591-D87D-4092-B35E-B8157890617CQ37482193-41B6570B-5800-481B-B55D-F737FC6A4C04Q37510348-2D1DF98C-967D-42A0-9BA0-2447707A65E1Q37682188-D076691E-43C1-4E60-B022-2ABD07776AB4Q37702782-3E930CAC-3D15-4195-AB30-836B5A85B9BAQ37768511-BE0205F2-BD48-42EE-8F66-1A8D937ACE09Q37818464-119A4BCC-5C03-4665-848E-2460BB4C25F9
P2860
description
article
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 1898
@uk
ലേഖനം
@ml
name
Niere und Kreislauf1
@en
Niere und Kreislauf1
@nl
type
label
Niere und Kreislauf1
@en
Niere und Kreislauf1
@nl
prefLabel
Niere und Kreislauf1
@en
Niere und Kreislauf1
@nl
P1476
Niere und Kreislauf1
@en
P2093
P. Q. Bergman
Robert Tigerstedt
P304
P356
10.1111/J.1748-1716.1898.TB00272.X
P577
1898-01-01T00:00:00Z